Proposed Cold MD settlement
This article was originally published in The Tan Sheet
Iomedix Cold International agrees to make refunds to consumers who bought the Cold MD dietary supplement between March 26, 2004, and May 29, 2009. Consumers could receive $5 to $10 per bottle that they purchased as part of a proposed class action settlement. The settlement would resolve allegations the Mississauga, Ontario-based firm made false claims about Cold MD, according to a July 7 press release. The National Advertising Division previously ruled Iovate failed to substantiate efficacy claims (1"The Tan Sheet" April 30, 2007)
You may also be interested in...
Iovate Health Sciences "strongly disagrees" with the National Advertising Division's recommendation to discontinue some product claims for its Cold MD dietary supplement, but said it will comply with the Council of Better Business Bureaus unit's April 20 decision
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.